CONSOLIDATED STATEMENT OF CASH FLOWS (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities:
Net income	$ 2,998,000,000	$ 2,676,000,000
Less: Net income attributable to the noncontrolling interest	21,000,000	1,000,000
Net income attributable to Honeywell	2,977,000,000	2,675,000,000
Adjustments to reconcile net income attributable to Honeywell to net cash provided by operating activities:
Depreciation and amortization	740,000,000	681,000,000
Gain on sale of non-strategic businesses and assets	0	(3,000,000)
Repositioning and other charges	419,000,000	356,000,000
Net payments for repositioning and other charges	(517,000,000)	(352,000,000)
Pension and other postretirement (income) expense	(61,000,000)	81,000,000
Pension and other postretirement benefit payments	(253,000,000)	(888,000,000)
Stock compensation expense	129,000,000	131,000,000
Deferred income taxes	257,000,000	319,000,000
Excess tax benefits from share based payment arrangements	(101,000,000)	(28,000,000)
Other	35,000,000	39,000,000
Changes in assets and liabilities, net of the effects of acquisitions and divestitures:
Accounts, notes and other receivables	(382,000,000)	(160,000,000)
Inventories	(94,000,000)	(53,000,000)
Other current assets	(28,000,000)	(77,000,000)
Accounts payable	(32,000,000)	(220,000,000)
Accrued liabilities	(422,000,000)	(333,000,000)
Net cash provided by operating activities	2,667,000,000	2,168,000,000
Cash flows from investing activities:
Expenditures for property, plant and equipment	(547,000,000)	(586,000,000)
Proceeds from disposals of property, plant and equipment	7,000,000	2,000,000
Increase in investments	(703,000,000)	(482,000,000)
Decrease in investments	648,000,000	287,000,000
Cash paid for acquisitions, net of cash acquired	(1,063,000,000)	(62,000,000)
Proceeds from sales of businesses, net of fees paid	0	18,000,000
Other	104,000,000	(42,000,000)
Net cash used for investing activities	(1,554,000,000)	(865,000,000)
Cash flows from financing activities:
Net increase in commercial paper	1,699,000,000	300,000,000
Net increase in short-term borrowings	18,000,000	19,000,000
Proceeds from issuance of common stock	362,000,000	179,000,000
Proceeds from issuance of long-term debt	27,000,000	86,000,000
Payments of long-term debt	(604,000,000)	0
Excess tax benefits from share based payment arrangements	101,000,000	28,000,000
Repurchases of common stock	(769,000,000)	0
Cash dividends paid	(995,000,000)	(880,000,000)
Other	28,000,000	0
Net cash used for financing activities	(133,000,000)	(268,000,000)
Effect of foreign exchange rate changes on cash and cash equivalents	(115,000,000)	27,000,000
Net increase in cash and cash equivalents	865,000,000	1,062,000,000
Cash and cash equivalents at beginning of period	4,634,000,000	3,698,000,000
Cash and cash equivalents at end of period	$ 5,499,000,000	$ 4,760,000,000